Concepedia

John G. Kuhn

JG

143

Publications

11.3K

Citations

62

H-Index

1980

Active since

Affiliations

The University of Texas Health Science Center at San Antonio(Current)

University of California, San Francisco

The University of Texas MD Anderson Cancer Center

Dana-Farber Cancer Institute

Brooke Army Medical Center

John G. Kuhn is an author at The University of Texas Health Science Center at San Antonio specializing in medicine, pharmacology, and pharmacotherapy.

ORCID

Top concepts

Publications per year

1980–2023

143

Publications

143

Progression-free survival: An important end point in evaluating therapy for recurrent high-grade gliomas

Kathleen R. Lamborn, W.K. Alfred Yung, Susan M. Chang et al. · Neuro-Oncology · 2008 · 416 citations · Full text

, , +17

Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme

Susan M. Chang, Patrick Y. Wen, Timothy F. Cloughesy et al. · Investigational New Drugs · 2005 · 400 citations · Full text

, , +9

Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer.

Mace L. Rothenberg, John R. Eckardt, John G. Kuhn et al. · Journal of Clinical Oncology · 1996 · 351 citations

Differential Sensitivity of Glioma- versus Lung Cancer–Specific EGFR Mutations to EGFR Kinase Inhibitors

Igor Vivanco, H. Ian Robins, Daniel Rohle et al. · Cancer Discovery · 2012 · 336 citations · Full text

EGFR Signaling Through an Akt-SREBP-1–Dependent, Rapamycin-Resistant Pathway Sensitizes Glioblastomas to Antilipogenic Therapy

Deliang Guo, Robert M. Prins, Julie Dang et al. · Science Signaling · 2009 · 335 citations · Full text

Rows per page

1–5 of 143